THROMBOTECT - a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents - Greiner, J; Schrappe, M; Claviez, A; THROMBOTECT Study Investigators (Haematologica, 2019)